Incyte Corp.
(NASDAQ : INCY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.07%171.501.3%$500.45m
BIIBBiogen Inc.
1.23%235.781.3%$485.16m
CELGCelgene Corporation
0.16%96.411.3%$469.40m
GILDGilead Sciences, Inc.
0.12%66.600.9%$452.70m
ILMNIllumina, Inc.
2.11%312.943.5%$316.33m
REGNRegeneron Pharmaceuticals, Inc.
2.81%318.672.6%$292.51m
AAgilent Technologies, Inc.
-0.16%68.211.6%$199.63m
VRTXVertex Pharmaceuticals Incorporated
2.41%173.201.9%$181.87m
EXASExact Sciences Corporation
-1.27%95.7225.3%$168.66m
ALXNAlexion Pharmaceuticals, Inc.
-0.93%127.602.0%$150.04m
BMRNBioMarin Pharmaceutical Inc.
0.63%88.024.3%$118.44m
SRPTSarepta Therapeutics, Inc.
0.89%122.2714.7%$116.51m
INCYIncyte Corporation
1.07%79.522.5%$107.88m
IONSIonis Pharmaceuticals, Inc.
-0.78%68.708.2%$98.58m
ALNYAlnylam Pharmaceuticals, Inc
1.02%68.569.2%$96.59m

Company Profile

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.